Article title: Women’s perspectives on the management and consequences of hyperemesis gravidarum – a descriptive interview study
Authors: Havnen G.C., Truong B.T., Do M.-L.H., Heitmann K., Holst L. and Nordeng H.
Journal:Scandinavian Journal of Primary Health Care
Bibliometrics: Volume 37, Number 01, pages 30–40
DOI:https://doi.org/10.1080/02813432.2019.1569424
When this article was first published online there was an error in Table 2.
The median week of Ondansetron initiation in Table 2 was presented with an incorrect standard deviation: “12.0 ± 30.9”. The median week of initiation with correct standard deviation is “12.0 ± 5.0”. The error did not affect any other results.
Table 2.
Pharmacologic treatment of hyperemesis gravidarum and effects.
| Number of patients; Total = 107 | Treatment initiation, GW | Efficacy |
|||
|---|---|---|---|---|---|
| None | Moderate | Good | |||
| n (%)a | Median ± SD | n (%) | n (%) | n (%) | |
| Metoclopramide | 76 (71.0) | 8.0 ± 2.8 | |||
| Continuous | 31 (40.8) | 8 (25.8) | 4 (12.9) | 19 (61.3) | |
| As needed | 43 (56.6) | 21 (48.8) | 4 (9.3) | 18 (41.9) | |
| Meclozine | 55 (51.4) | 7.0 ± 3.4 | |||
| Continuous | 26 (47.3) | 9 (34.6) | 5 (19.2) | 12 (46.2) | |
| As needed | 29 (52.7) | 22 (75.9) | 1 (3.4) | 6 (20.7) | |
| Ondansetron | 31 (29.0) | 12.0 ± 5.0 | |||
| Continuous | 14 (45.2) | 1 (7.1) | 1 (7.1) | 12 (85.7) | |
| As needed | 14 (45.2) | 4 (28.6) | 2 (14.3) | 8 (57.1) | |
| Promethazine | 28 (26.2) | 10.0 ± 5.3 | |||
| Continuous | 9 (32.1) | 2 (22.2) | 5 (55.6) | 2 (22.2) | |
| As needed | 17 (60.7) | 9 (52.9) | 6 (35.3) | 2 (11.8) | |
| Prochlorperazine | 12 (11.2) | 9.5 ± 2.9 | |||
| Continuous | 4 (33.3) | 0 (0.0) | 2 (50.0) | 2 (50.0) | |
| As needed | 7 (58.3) | 4 (57.1) | 2 (28.6) | 1 (14.3) | |
| Chlorpromazine | 11 (10.3) | 9.0 ± 7.6 | |||
| Continuous | 2 (18.2) | 0 (0.0) | 1 (50.0) | 1 (50.0) | |
| As needed | 6 (54.5) | 2 (33.3) | 3 (50.0) | 1 (16.7) | |
Data obtained from the interview. GW: gestational week; SD: standard deviation.
aTotal numbers do not add up for the resepective medications, due to missing values for metoclopramide (n = 2), ondansetron (n = 3), promethazine (n = 2), prochlorperazine (n = 1), and chlorpromazine (n = 3).